nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Gastrointestinal motility disorder—Capecitabine—esophageal cancer	0.071	0.139	CcSEcCtD
Ipratropium bromide—SLC22A4—larynx—esophageal cancer	0.0424	0.281	CbGeAlD
Ipratropium bromide—CHRM3—exocrine gland—esophageal cancer	0.0139	0.0919	CbGeAlD
Ipratropium bromide—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.0122	0.0239	CcSEcCtD
Ipratropium bromide—Congenital anomaly—Capecitabine—esophageal cancer	0.0113	0.0221	CcSEcCtD
Ipratropium bromide—Developmental delay—Capecitabine—esophageal cancer	0.0113	0.0221	CcSEcCtD
Ipratropium bromide—SLC22A4—neck—esophageal cancer	0.0112	0.0744	CbGeAlD
Ipratropium bromide—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.0111	0.0219	CcSEcCtD
Ipratropium bromide—CHRM5—epithelium—esophageal cancer	0.0108	0.0715	CbGeAlD
Ipratropium bromide—Hoarseness—Capecitabine—esophageal cancer	0.00972	0.0191	CcSEcCtD
Ipratropium bromide—Disorder sight—Capecitabine—esophageal cancer	0.00898	0.0176	CcSEcCtD
Ipratropium bromide—SLC22A4—bronchus—esophageal cancer	0.00753	0.0499	CbGeAlD
Ipratropium bromide—Infection—Carboplatin—esophageal cancer	0.00701	0.0138	CcSEcCtD
Ipratropium bromide—SLC22A4—trachea—esophageal cancer	0.00676	0.0448	CbGeAlD
Ipratropium bromide—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00653	0.0128	CcSEcCtD
Ipratropium bromide—Intestinal obstruction—Capecitabine—esophageal cancer	0.00627	0.0123	CcSEcCtD
Ipratropium bromide—Ulcer—Cisplatin—esophageal cancer	0.00613	0.012	CcSEcCtD
Ipratropium bromide—Pain—Carboplatin—esophageal cancer	0.00603	0.0118	CcSEcCtD
Ipratropium bromide—CHRM1—trachea—esophageal cancer	0.00597	0.0395	CbGeAlD
Ipratropium bromide—Tongue disorder—Capecitabine—esophageal cancer	0.00588	0.0115	CcSEcCtD
Ipratropium bromide—CHRM3—smooth muscle tissue—esophageal cancer	0.00582	0.0385	CbGeAlD
Ipratropium bromide—SLC22A4—digestive system—esophageal cancer	0.00582	0.0385	CbGeAlD
Ipratropium bromide—Wheezing—Cisplatin—esophageal cancer	0.00563	0.0111	CcSEcCtD
Ipratropium bromide—Dysphonia—Capecitabine—esophageal cancer	0.0052	0.0102	CcSEcCtD
Ipratropium bromide—Eye irritation—Capecitabine—esophageal cancer	0.00501	0.00983	CcSEcCtD
Ipratropium bromide—SLC22A5—bronchus—esophageal cancer	0.00498	0.033	CbGeAlD
Ipratropium bromide—SLC22A4—lung—esophageal cancer	0.00486	0.0322	CbGeAlD
Ipratropium bromide—Nasal congestion—Cisplatin—esophageal cancer	0.00462	0.00908	CcSEcCtD
Ipratropium bromide—CHRM3—digestive system—esophageal cancer	0.0046	0.0304	CbGeAlD
Ipratropium bromide—Ulcer—Capecitabine—esophageal cancer	0.00452	0.00888	CcSEcCtD
Ipratropium bromide—Lung disorder—Methotrexate—esophageal cancer	0.0045	0.00883	CcSEcCtD
Ipratropium bromide—SLC22A5—trachea—esophageal cancer	0.00448	0.0296	CbGeAlD
Ipratropium bromide—Inflammation—Capecitabine—esophageal cancer	0.00441	0.00866	CcSEcCtD
Ipratropium bromide—CHRM1—lung—esophageal cancer	0.00429	0.0284	CbGeAlD
Ipratropium bromide—Influenza like illness—Capecitabine—esophageal cancer	0.00415	0.00815	CcSEcCtD
Ipratropium bromide—SLC22A5—digestive system—esophageal cancer	0.00385	0.0255	CbGeAlD
Ipratropium bromide—Abnormal vision—Capecitabine—esophageal cancer	0.00373	0.00732	CcSEcCtD
Ipratropium bromide—Swelling—Capecitabine—esophageal cancer	0.00352	0.00691	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Cisplatin—esophageal cancer	0.00349	0.00685	CcSEcCtD
Ipratropium bromide—Eye pain—Capecitabine—esophageal cancer	0.00344	0.00675	CcSEcCtD
Ipratropium bromide—Ulcer—Methotrexate—esophageal cancer	0.00337	0.00661	CcSEcCtD
Ipratropium bromide—SLC22A4—lymph node—esophageal cancer	0.00332	0.022	CbGeAlD
Ipratropium bromide—Inflammation—Methotrexate—esophageal cancer	0.00328	0.00644	CcSEcCtD
Ipratropium bromide—Atrial fibrillation—Capecitabine—esophageal cancer	0.00328	0.00643	CcSEcCtD
Ipratropium bromide—Thirst—Capecitabine—esophageal cancer	0.00326	0.0064	CcSEcCtD
Ipratropium bromide—SLC22A5—lung—esophageal cancer	0.00322	0.0213	CbGeAlD
Ipratropium bromide—Arthritis—Capecitabine—esophageal cancer	0.00319	0.00627	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00318	0.00625	CcSEcCtD
Ipratropium bromide—Stomatitis—Cisplatin—esophageal cancer	0.00316	0.00621	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Cisplatin—esophageal cancer	0.00315	0.00619	CcSEcCtD
Ipratropium bromide—Urinary retention—Capecitabine—esophageal cancer	0.00295	0.00579	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Cisplatin—esophageal cancer	0.00288	0.00565	CcSEcCtD
Ipratropium bromide—Urethral disorder—Cisplatin—esophageal cancer	0.00286	0.00561	CcSEcCtD
Ipratropium bromide—Visual impairment—Cisplatin—esophageal cancer	0.00281	0.00551	CcSEcCtD
Ipratropium bromide—Eye disorder—Cisplatin—esophageal cancer	0.00272	0.00534	CcSEcCtD
Ipratropium bromide—Tinnitus—Cisplatin—esophageal cancer	0.00272	0.00533	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Cisplatin—esophageal cancer	0.0027	0.00531	CcSEcCtD
Ipratropium bromide—Flushing—Cisplatin—esophageal cancer	0.0027	0.00531	CcSEcCtD
Ipratropium bromide—Influenza—Capecitabine—esophageal cancer	0.00268	0.00527	CcSEcCtD
Ipratropium bromide—Asthma—Capecitabine—esophageal cancer	0.00268	0.00527	CcSEcCtD
Ipratropium bromide—Dysphagia—Capecitabine—esophageal cancer	0.00268	0.00527	CcSEcCtD
Ipratropium bromide—Bronchospasm—Capecitabine—esophageal cancer	0.00264	0.00518	CcSEcCtD
Ipratropium bromide—Immune system disorder—Cisplatin—esophageal cancer	0.00263	0.00517	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Cisplatin—esophageal cancer	0.00263	0.00515	CcSEcCtD
Ipratropium bromide—Bronchitis—Capecitabine—esophageal cancer	0.00258	0.00507	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Capecitabine—esophageal cancer	0.00257	0.00505	CcSEcCtD
Ipratropium bromide—CYP3A4—digestive system—esophageal cancer	0.00253	0.0167	CbGeAlD
Ipratropium bromide—Dysuria—Capecitabine—esophageal cancer	0.00251	0.00493	CcSEcCtD
Ipratropium bromide—Flatulence—Cisplatin—esophageal cancer	0.0025	0.00491	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00249	0.0049	CcSEcCtD
Ipratropium bromide—CYP2D6—digestive system—esophageal cancer	0.00248	0.0165	CbGeAlD
Ipratropium bromide—Vision blurred—Cisplatin—esophageal cancer	0.00239	0.00469	CcSEcCtD
Ipratropium bromide—Tremor—Cisplatin—esophageal cancer	0.00238	0.00466	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00235	0.0046	CcSEcCtD
Ipratropium bromide—Stomatitis—Capecitabine—esophageal cancer	0.00233	0.00458	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Capecitabine—esophageal cancer	0.00233	0.00457	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Capecitabine—esophageal cancer	0.00233	0.00457	CcSEcCtD
Ipratropium bromide—Epistaxis—Capecitabine—esophageal cancer	0.00226	0.00443	CcSEcCtD
Ipratropium bromide—SLC22A5—lymph node—esophageal cancer	0.0022	0.0146	CbGeAlD
Ipratropium bromide—Myalgia—Cisplatin—esophageal cancer	0.00216	0.00424	CcSEcCtD
Ipratropium bromide—Haemoglobin—Capecitabine—esophageal cancer	0.00216	0.00424	CcSEcCtD
Ipratropium bromide—Rhinitis—Capecitabine—esophageal cancer	0.00215	0.00423	CcSEcCtD
Ipratropium bromide—Haemorrhage—Capecitabine—esophageal cancer	0.00215	0.00422	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00214	0.00421	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Capecitabine—esophageal cancer	0.00214	0.00419	CcSEcCtD
Ipratropium bromide—Pharyngitis—Capecitabine—esophageal cancer	0.00213	0.00418	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Capecitabine—esophageal cancer	0.00212	0.00416	CcSEcCtD
Ipratropium bromide—Urethral disorder—Capecitabine—esophageal cancer	0.00211	0.00413	CcSEcCtD
Ipratropium bromide—Oedema—Cisplatin—esophageal cancer	0.00207	0.00406	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Cisplatin—esophageal cancer	0.00207	0.00406	CcSEcCtD
Ipratropium bromide—Visual impairment—Capecitabine—esophageal cancer	0.00207	0.00406	CcSEcCtD
Ipratropium bromide—Infection—Cisplatin—esophageal cancer	0.00206	0.00404	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Cisplatin—esophageal cancer	0.00203	0.00398	CcSEcCtD
Ipratropium bromide—Tachycardia—Cisplatin—esophageal cancer	0.00202	0.00397	CcSEcCtD
Ipratropium bromide—Skin disorder—Cisplatin—esophageal cancer	0.00201	0.00395	CcSEcCtD
Ipratropium bromide—Eye disorder—Capecitabine—esophageal cancer	0.00201	0.00394	CcSEcCtD
Ipratropium bromide—Tinnitus—Capecitabine—esophageal cancer	0.002	0.00393	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Cisplatin—esophageal cancer	0.002	0.00393	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—esophageal cancer	0.002	0.00392	CcSEcCtD
Ipratropium bromide—Flushing—Capecitabine—esophageal cancer	0.00199	0.00391	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Capecitabine—esophageal cancer	0.00199	0.00391	CcSEcCtD
Ipratropium bromide—Immune system disorder—Capecitabine—esophageal cancer	0.00194	0.00381	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Capecitabine—esophageal cancer	0.00194	0.0038	CcSEcCtD
Ipratropium bromide—Hypotension—Cisplatin—esophageal cancer	0.00193	0.0038	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Methotrexate—esophageal cancer	0.00191	0.00376	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00189	0.0037	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—esophageal cancer	0.00187	0.00367	CcSEcCtD
Ipratropium bromide—Paraesthesia—Cisplatin—esophageal cancer	0.00186	0.00365	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00186	0.00364	CcSEcCtD
Ipratropium bromide—Dyspnoea—Cisplatin—esophageal cancer	0.00185	0.00362	CcSEcCtD
Ipratropium bromide—Flatulence—Capecitabine—esophageal cancer	0.00184	0.00362	CcSEcCtD
Ipratropium bromide—Dysgeusia—Capecitabine—esophageal cancer	0.00183	0.00359	CcSEcCtD
Ipratropium bromide—Back pain—Capecitabine—esophageal cancer	0.00181	0.00355	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00179	0.00351	CcSEcCtD
Ipratropium bromide—Pain—Cisplatin—esophageal cancer	0.00177	0.00347	CcSEcCtD
Ipratropium bromide—Vision blurred—Capecitabine—esophageal cancer	0.00176	0.00346	CcSEcCtD
Ipratropium bromide—Tremor—Capecitabine—esophageal cancer	0.00175	0.00344	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—esophageal cancer	0.00174	0.00341	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—esophageal cancer	0.00173	0.0034	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—esophageal cancer	0.00171	0.00335	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—esophageal cancer	0.00168	0.0033	CcSEcCtD
Ipratropium bromide—Palpitations—Capecitabine—esophageal cancer	0.00165	0.00324	CcSEcCtD
Ipratropium bromide—Cough—Capecitabine—esophageal cancer	0.00163	0.0032	CcSEcCtD
Ipratropium bromide—Hypertension—Capecitabine—esophageal cancer	0.00161	0.00317	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—esophageal cancer	0.00161	0.00315	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—esophageal cancer	0.0016	0.00314	CcSEcCtD
Ipratropium bromide—Chest pain—Capecitabine—esophageal cancer	0.00159	0.00312	CcSEcCtD
Ipratropium bromide—Myalgia—Capecitabine—esophageal cancer	0.00159	0.00312	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—esophageal cancer	0.00159	0.00311	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00158	0.0031	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—esophageal cancer	0.00158	0.0031	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—esophageal cancer	0.00157	0.00308	CcSEcCtD
Ipratropium bromide—Dry mouth—Capecitabine—esophageal cancer	0.00156	0.00306	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—esophageal cancer	0.00154	0.00302	CcSEcCtD
Ipratropium bromide—Oedema—Capecitabine—esophageal cancer	0.00153	0.003	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cisplatin—esophageal cancer	0.00153	0.00299	CcSEcCtD
Ipratropium bromide—Infection—Capecitabine—esophageal cancer	0.00152	0.00298	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Capecitabine—esophageal cancer	0.0015	0.00294	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—esophageal cancer	0.00149	0.00293	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—esophageal cancer	0.00149	0.00293	CcSEcCtD
Ipratropium bromide—Tachycardia—Capecitabine—esophageal cancer	0.00149	0.00292	CcSEcCtD
Ipratropium bromide—Asthenia—Cisplatin—esophageal cancer	0.00149	0.00292	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—esophageal cancer	0.00148	0.00291	CcSEcCtD
Ipratropium bromide—Skin disorder—Capecitabine—esophageal cancer	0.00148	0.00291	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Capecitabine—esophageal cancer	0.00148	0.0029	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—esophageal cancer	0.00144	0.00283	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—esophageal cancer	0.00144	0.00283	CcSEcCtD
Ipratropium bromide—Hypotension—Capecitabine—esophageal cancer	0.00143	0.0028	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cisplatin—esophageal cancer	0.00142	0.00278	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00139	0.00273	CcSEcCtD
Ipratropium bromide—Insomnia—Capecitabine—esophageal cancer	0.00138	0.00271	CcSEcCtD
Ipratropium bromide—Paraesthesia—Capecitabine—esophageal cancer	0.00137	0.00269	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—esophageal cancer	0.00136	0.00268	CcSEcCtD
Ipratropium bromide—Dyspnoea—Capecitabine—esophageal cancer	0.00136	0.00267	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—esophageal cancer	0.00135	0.00264	CcSEcCtD
Ipratropium bromide—Dyspepsia—Capecitabine—esophageal cancer	0.00134	0.00264	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00132	0.00259	CcSEcCtD
Ipratropium bromide—Vomiting—Cisplatin—esophageal cancer	0.00132	0.00258	CcSEcCtD
Ipratropium bromide—Fatigue—Capecitabine—esophageal cancer	0.00132	0.00258	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—esophageal cancer	0.00131	0.00257	CcSEcCtD
Ipratropium bromide—Rash—Cisplatin—esophageal cancer	0.00131	0.00256	CcSEcCtD
Ipratropium bromide—Pain—Capecitabine—esophageal cancer	0.0013	0.00256	CcSEcCtD
Ipratropium bromide—Constipation—Capecitabine—esophageal cancer	0.0013	0.00256	CcSEcCtD
Ipratropium bromide—Dermatitis—Cisplatin—esophageal cancer	0.0013	0.00256	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00125	0.00245	CcSEcCtD
Ipratropium bromide—Nausea—Cisplatin—esophageal cancer	0.00123	0.00241	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—esophageal cancer	0.00121	0.00238	CcSEcCtD
Ipratropium bromide—Urticaria—Capecitabine—esophageal cancer	0.00121	0.00238	CcSEcCtD
Ipratropium bromide—Abdominal pain—Capecitabine—esophageal cancer	0.00121	0.00237	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—esophageal cancer	0.00118	0.00233	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—esophageal cancer	0.00118	0.00233	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00118	0.00231	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—esophageal cancer	0.00114	0.00223	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—esophageal cancer	0.00113	0.00222	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Capecitabine—esophageal cancer	0.00112	0.00221	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—esophageal cancer	0.00111	0.00219	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—esophageal cancer	0.0011	0.00217	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—esophageal cancer	0.0011	0.00216	CcSEcCtD
Ipratropium bromide—Asthenia—Capecitabine—esophageal cancer	0.00109	0.00215	CcSEcCtD
Ipratropium bromide—Pruritus—Capecitabine—esophageal cancer	0.00108	0.00212	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—esophageal cancer	0.00106	0.00208	CcSEcCtD
Ipratropium bromide—Diarrhoea—Capecitabine—esophageal cancer	0.00104	0.00205	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00103	0.00203	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—esophageal cancer	0.00103	0.00202	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—esophageal cancer	0.00102	0.002	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—esophageal cancer	0.00101	0.00199	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—esophageal cancer	0.00101	0.00198	CcSEcCtD
Ipratropium bromide—Dizziness—Capecitabine—esophageal cancer	0.00101	0.00198	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—esophageal cancer	0.001	0.00196	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000981	0.00193	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—esophageal cancer	0.000979	0.00192	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—esophageal cancer	0.000971	0.00191	CcSEcCtD
Ipratropium bromide—Vomiting—Capecitabine—esophageal cancer	0.00097	0.0019	CcSEcCtD
Ipratropium bromide—Rash—Capecitabine—esophageal cancer	0.000962	0.00189	CcSEcCtD
Ipratropium bromide—Dermatitis—Capecitabine—esophageal cancer	0.000961	0.00189	CcSEcCtD
Ipratropium bromide—Headache—Capecitabine—esophageal cancer	0.000956	0.00188	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000929	0.00182	CcSEcCtD
Ipratropium bromide—Nausea—Capecitabine—esophageal cancer	0.000906	0.00178	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—esophageal cancer	0.000902	0.00177	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—esophageal cancer	0.000898	0.00176	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—esophageal cancer	0.000837	0.00164	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—esophageal cancer	0.000815	0.0016	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—esophageal cancer	0.000804	0.00158	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—esophageal cancer	0.000777	0.00153	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—esophageal cancer	0.000751	0.00147	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—esophageal cancer	0.000722	0.00142	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—esophageal cancer	0.000716	0.00141	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—esophageal cancer	0.000716	0.0014	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—esophageal cancer	0.000712	0.0014	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—esophageal cancer	0.000675	0.00132	CcSEcCtD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	0.000192	0.000565	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—SST—esophageal cancer	0.000192	0.000565	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—SST—esophageal cancer	0.000191	0.000563	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP26A1—esophageal cancer	0.00019	0.00056	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.00019	0.00056	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000189	0.000557	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000187	0.00055	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000186	0.000548	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000185	0.000546	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000184	0.000543	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—GNG7—esophageal cancer	0.000183	0.00054	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000181	0.000532	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.00018	0.00053	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000179	0.000527	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000178	0.000525	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000178	0.000525	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—TPI1—esophageal cancer	0.000177	0.000521	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTO1—esophageal cancer	0.000177	0.000521	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000177	0.00052	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000174	0.000513	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.000174	0.000511	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000172	0.000506	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—XIAP—esophageal cancer	0.000172	0.000506	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000171	0.000504	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000171	0.000503	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	0.00017	0.0005	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALDOB—esophageal cancer	0.00017	0.000499	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000169	0.000498	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PFN1—esophageal cancer	0.000169	0.000498	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000168	0.000496	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.000167	0.000493	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.000167	0.000491	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000166	0.00049	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000166	0.000488	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000164	0.000483	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CA1—esophageal cancer	0.000164	0.000483	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000163	0.000481	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CTNNA1—esophageal cancer	0.000162	0.000478	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CRABP1—esophageal cancer	0.000162	0.000476	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL2—esophageal cancer	0.000161	0.000476	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GNG7—esophageal cancer	0.000154	0.000453	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000152	0.000447	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	0.000152	0.000447	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	0.000151	0.000446	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PSME2—esophageal cancer	0.000151	0.000444	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PSME1—esophageal cancer	0.000151	0.000444	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ANXA1—esophageal cancer	0.00015	0.000442	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CA2—esophageal cancer	0.00015	0.000442	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.00015	0.000441	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000149	0.000438	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000148	0.000437	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000148	0.000436	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.000148	0.000436	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000146	0.000431	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SST—esophageal cancer	0.000146	0.00043	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000144	0.000425	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—GHRL—esophageal cancer	0.000142	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOTCH3—esophageal cancer	0.000142	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FBXW7—esophageal cancer	0.00014	0.000412	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.00014	0.000411	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADH7—esophageal cancer	0.00014	0.000411	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTT1—esophageal cancer	0.000137	0.000404	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000137	0.000403	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000136	0.000402	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000136	0.0004	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.000136	0.000399	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.000135	0.000398	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000135	0.000398	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000134	0.000394	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000129	0.00038	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.000129	0.000379	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS1—esophageal cancer	0.000128	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ENO1—esophageal cancer	0.000128	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOTCH2—esophageal cancer	0.000128	0.000376	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000127	0.000375	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PSME2—esophageal cancer	0.000127	0.000373	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PSME1—esophageal cancer	0.000127	0.000373	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000126	0.000372	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000126	0.000372	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000122	0.00036	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.000121	0.000356	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000121	0.000355	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000119	0.000352	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000117	0.000344	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000114	0.000337	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.000114	0.000336	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000114	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000114	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000113	0.000334	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFBR2—esophageal cancer	0.000113	0.000334	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.000113	0.000332	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.000112	0.000331	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000111	0.000326	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000109	0.000322	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CA1—esophageal cancer	0.000107	0.000316	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000107	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SMAD4—esophageal cancer	0.000107	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.000106	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.000106	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.000106	0.000312	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.000106	0.000312	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000106	0.000311	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000106	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000106	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000105	0.00031	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.000105	0.000309	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.000105	0.000309	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.000104	0.000307	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SST—esophageal cancer	0.000103	0.000303	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.000103	0.000303	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SST—esophageal cancer	0.000102	0.000302	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000102	0.000299	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000101	0.000299	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.0001	0.000295	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.0001	0.000295	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	9.99e-05	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GHRL—esophageal cancer	9.99e-05	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	9.89e-05	0.000291	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GHRL—esophageal cancer	9.89e-05	0.000291	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	9.86e-05	0.00029	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	9.83e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CA2—esophageal cancer	9.81e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GAPDH—esophageal cancer	9.76e-05	0.000287	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	9.73e-05	0.000287	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.67e-05	0.000285	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—HMOX1—esophageal cancer	9.37e-05	0.000276	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GNG7—esophageal cancer	9.2e-05	0.000271	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADH7—esophageal cancer	9.12e-05	0.000269	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.12e-05	0.000269	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ABCB1—esophageal cancer	9e-05	0.000265	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	8.99e-05	0.000265	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	8.96e-05	0.000264	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	8.87e-05	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	8.77e-05	0.000258	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.62e-05	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KDR—esophageal cancer	8.39e-05	0.000247	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTT1—esophageal cancer	8.2e-05	0.000241	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP2A6—esophageal cancer	8.1e-05	0.000239	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADH1B—esophageal cancer	8e-05	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	7.97e-05	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	7.95e-05	0.000234	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	7.9e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	7.87e-05	0.000232	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.68e-05	0.000226	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ENO1—esophageal cancer	7.68e-05	0.000226	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TYMP—esophageal cancer	7.64e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSME2—esophageal cancer	7.57e-05	0.000223	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSME1—esophageal cancer	7.57e-05	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	7.55e-05	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	7.52e-05	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	7.45e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.44e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.25e-05	0.000213	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	7.16e-05	0.000211	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	7.04e-05	0.000207	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TPI1—esophageal cancer	6.91e-05	0.000204	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.91e-05	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	6.73e-05	0.000198	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.63e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.53e-05	0.000192	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOS3—esophageal cancer	6.41e-05	0.000189	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.38e-05	0.000188	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.32e-05	0.000186	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	6.18e-05	0.000182	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	6.16e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP19A1—esophageal cancer	6.14e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	6.11e-05	0.00018	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	6.1e-05	0.00018	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GNG7—esophageal cancer	6.01e-05	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CREBBP—esophageal cancer	6.01e-05	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	6e-05	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KDR—esophageal cancer	5.91e-05	0.000174	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KDR—esophageal cancer	5.89e-05	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KDR—esophageal cancer	5.83e-05	0.000172	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.64e-05	0.000166	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.6e-05	0.000165	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	5.56e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	5.55e-05	0.000163	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	5.49e-05	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NOS3—esophageal cancer	5.38e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.38e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.36e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCND1—esophageal cancer	5.3e-05	0.000156	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.3e-05	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	5.13e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	5.04e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	5.03e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ENO1—esophageal cancer	5.02e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.02e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	4.98e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	4.96e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSME1—esophageal cancer	4.95e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSME2—esophageal cancer	4.95e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	4.94e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—esophageal cancer	4.92e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	4.89e-05	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EP300—esophageal cancer	4.88e-05	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	4.74e-05	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	4.72e-05	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	4.68e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOS3—esophageal cancer	4.52e-05	0.000133	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOS3—esophageal cancer	4.5e-05	0.000133	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOS3—esophageal cancer	4.46e-05	0.000131	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	4.3e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	4.29e-05	0.000126	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.27e-05	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—esophageal cancer	4.25e-05	0.000125	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	4.25e-05	0.000125	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	4.22e-05	0.000124	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	4.21e-05	0.000124	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	4.17e-05	0.000123	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EGFR—esophageal cancer	4.16e-05	0.000122	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—EP300—esophageal cancer	4.1e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.02e-05	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCND1—esophageal cancer	3.73e-05	0.00011	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCND1—esophageal cancer	3.72e-05	0.00011	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCND1—esophageal cancer	3.68e-05	0.000109	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.66e-05	0.000108	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	3.61e-05	0.000106	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	3.61e-05	0.000106	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	3.6e-05	0.000106	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.6e-05	0.000106	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	3.56e-05	0.000105	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.52e-05	0.000104	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TP53—esophageal cancer	3.49e-05	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EP300—esophageal cancer	3.44e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EP300—esophageal cancer	3.42e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EP300—esophageal cancer	3.39e-05	9.99e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NOS3—esophageal cancer	3.22e-05	9.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CA—esophageal cancer	3.03e-05	8.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—esophageal cancer	2.99e-05	8.82e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—esophageal cancer	2.98e-05	8.79e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—esophageal cancer	2.96e-05	8.7e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.94e-05	8.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EGFR—esophageal cancer	2.93e-05	8.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EGFR—esophageal cancer	2.92e-05	8.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EGFR—esophageal cancer	2.89e-05	8.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	2.54e-05	7.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	2.53e-05	7.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	2.51e-05	7.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TP53—esophageal cancer	2.46e-05	7.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TP53—esophageal cancer	2.45e-05	7.22e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—EP300—esophageal cancer	2.45e-05	7.21e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TP53—esophageal cancer	2.43e-05	7.15e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.35e-05	6.92e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NOS3—esophageal cancer	2.1e-05	6.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.92e-05	5.67e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.81e-05	5.34e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—EP300—esophageal cancer	1.6e-05	4.72e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.18e-05	3.49e-05	CbGpPWpGaD
